You are here: Home / Archives for NEWS BLOG . . . . . . . . / Science & Medicine / Cancer

HPV Vaccines versus Pap Screening

May 6, 2012 By 1 Comment

[SaneVax: March 12, 2012, the ASCP  released new pap screening guidelines. According to Dr. Mark Stoler, past president of ASCP, said, "The Pap test remains among the most effective tools ever devised to prevent cancer and cancer deaths."

Please note the fifth bullet point in the excerpt below. Obviously, Dr. Stoler and the American Society of Clinical Pathologists have never heard the saying, "If its not broke, don't fix it." Or, could it be they have simply become marketing agents for the manufacturers of HPV vaccines?]

To Pap or Not to Pap: What the New Cervical Cancer Screening Guidelines Mean for Women

Excerpt from a Press Release by the ASCP

New Cervical Cancer Screening Guidelines Now Available at http://ajcp.ascpjournals.org/.

Following is what women need to know about the new guidelines and recommendations for cervical cancer screening:

  • Not until age 21: Women shouldn’t get a Pap test until they’re 21 years old, even if they’ve been sexually active.
  • Every three years: Women should have a Pap test once every three years from ages 21 to 29.
  • After age 30: After 30, women should have a Pap test combined with testing for HPV every five years. HPV is a virus that can cause cervical cancer. An acceptable alternative is to continue having a Pap test alone every three years.
  • Over age 65: Women over 65 should stop getting cervical cancer screening tests altogether, as long as they’ve had at least three consecutive normal Pap tests or two negative HPV tests in the previous 10 years (the most recent in the previous five years), unless they have a history of pre-cancer. In that case, women should continue routine screening for 20 years.
  • HPV vaccination isn’t a factor: Whether or not a woman has had the HPV vaccine, she should continue to follow the above recommendations because the vaccine does not protect against all HPV strains that can cause cervical cancer.
  • After hysterectomy: If a woman has had a hysterectomy and the cervix was removed, she should not be screened at all, as long as there is no history of pre-cancer.

Read the entire press release here.

Filed Under: Cervical Cancer, Pap Testing Tagged With: , , ,

Dormant HPV Infections Can Cause Disease Even Without Activating

March 18, 2012 By Leave a Comment

Microcompetition explains the underlying cause of many major diseases and shows how dormant viruses actually can cause disease while still dormant.

Center for the Biology of Chronic Disease
Rochester, New York (PRWEB) March 17, 2012

PRESS RELEASE – PR Web

According to the FDA, active viruses cause disease; dormant viruses do not. The Center for the Biology of Chronic Disease (CBCD), in contrast, supports an alternative view. Microcompetition explains the underlying cause of many major diseases and shows how dormant viruses actually can cause disease while still dormant.

Why is this important? It is important because HPV has the ability to establish a dormant (latent) infection. Most people who have an HPV infection do not know they are infected because many types of the virus remain latent and cause no symptoms.

The FDA says people shouldn’t be worried about a dormant infection. The CBCD says otherwise.
A recent study entitled “Prevelance of Oral HPV Infection in the United States, 2009 – 2010” that was published in the Journal of the American Medical Association (JAMA) reported that the HPV virus was found in the mouths of 7% of study participants. 5,600 people participated in the study. Oral HPV was found in men more than in women. [1]

The authors of the study wrote, “The prevalence of oral HPV infection among men and women aged 14 to 69 years in the United States is approximately 7%… Infection with HPV-16, (a specific type of HPV most associated with cancer) was detected in 1% of men and women, corresponding to an estimated 2.13 million infected individuals in the United States.”

HPV has the ability to establish a chronic, dormant (latent) infection. Chronic infections can lead to cancer.

In essence, according to the study, 2.13 million people who don’t have symptoms now, and don’t even know they are infected, could develop cancer due to their HPV infection.

In contrast to the FDA’s claims, the CBCD believes this is true regardless of whether the virus is active or dormant.

According to Dr. Hanan Polansky, the dormant HPV virus microcompetes with human genes for scarce genetic resources, and as a result, can drive the human genes to malfunction, which eventually causes illnesses. In fact, according to Dr. Hanan Polansky’s highly acclaimed “Purple Book,” entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease,” dormant viruses, in high concentration, are the cause of many major diseases, such as cancer, heart disease, diabetes, arthritis, and many more.

The CBCD encourages biologists, virologists, physicians and those at the FDA and CDC to download and read Dr. Polansky’s book in depth.

Some scientists believe that if a virus is latent, then microcompetition is irrelevant. This belief is simply wrong. A dormant virus is not dead. It continues to express some of its proteins and therefore microcompetes with human genes.

Consider the paper entitled “Human Cytomegalovirus Persistence” published February 13, 2012 in the Journal Cellular Microbiology. [2]

Read Full Release

Filed Under: Cervical Cancer, HPV Science, United States Tagged With: , , ,

Fighting Cervical Cancer With Vinegar and Ingenuity

February 22, 2012 By 1 Comment

By DONALD G. McNEIL Jr.

 POYAI, Thailand — Maikaew Panomyai did a little dance coming out of the examination room, switching her hips,        waving her fists in the air and crowing, in her limited English: “Everything’s O.K.! Everything’s O.K.!”

Translation: The nurse just told me I do not have cervical cancer, and even the little white spot I had treated three years ago is still gone.

What allowed the nurse to render that reassuring diagnosis was a remarkably simple, brief and inexpensive procedure, one with the potential to do for poor countries what the Pap smear did for rich ones: end cervical cancer’s reign as the No. 1 cancer killer of women. The magic ingredient? Household vinegar.

 Every year, more than 250,000 women die of cervical cancer, nearly 85 percent of them in poor and middle-  income countries. Decades ago, it killed more American women than any other cancer; now it lags far behind cancers of the lung, breast, colon and skin.

Nurses using the new procedure, developed by experts at the Johns Hopkins medical school in the 1990s and endorsed last year by the World Health Organization, brush vinegar on a woman’s cervix. It makes precancerous spots turn white. They can then be immediately frozen off with a metal probe cooled by a tank of carbon dioxide, available from any Coca-Cola bottling plant.

The procedure is one of a wide array of inexpensive but effective medical advances being tested in developing countries. New cheap diagnostic and surgical techniques, insecticides, drug regimens and prostheses are already beginning to save lives.

Read the entire article here.

Filed Under: Cervical Cancer, Thailand Tagged With: , ,

3 Powerful Facts Discovered About Suppressed Cancer Treatments and the American Medical Association

February 21, 2012 By Leave a Comment

By Jeffry John Aufderheide

Suppression of Science?

Public and private funds have been thrown around like confetti at a country fair to close up and destroy clinics, hospitals, and scientific research laboratories which do not conform to the viewpoint of medical associations,” stated Benedict Fitzgerald. [1]

Fitzgerald was special counsel to the Senate Interstate and Foreign Commerce Committee in 1953. He was commissioned by Congressman Charles Tobey of Massachusetts to investigate the obstruction of natural cancer treatments by the American Medical Association.

His report to the committee is known as “The Fitzgerald Report” of 1953.

Alone, this information is a bombshell. But, to my knowledge the information you are about to read hasn’t been put into the same or connect-the-dots context before.

If anything else, know this simple fact: While the AMA was actively suppressing natural cures for cancer, millions of Americans were being injected with vaccines contaminated with a cancer-causing monkey virus, SV40.

Before I tell you what Fitzgerald concluded, you may be thinking this information is from the 1950s so it is outdated and can be discredited.

Please realize, though, the ‘success’ of the Rockefeller-funded polio vaccine program set the precedent for the entire U.S. vaccine program, which apparently is being followed to this day. With the explosion of cancer in the United States, this information deserves serious consideration and further investigation.

Additionally, I’m going to give you evidence of congressional testimony that cancer was in those vaccines, and that fact was covered up. If you want to know more, read on.

FACT #1: FITZGERALD EXPOSES THE AMERICAN MEDICAL ASSOCIATION FOR SUPPRESSING CANCER CURES

 

Read the entire article here.

Filed Under: Cancer Tagged With: , ,

3 changes to children’s vaccine recommendations announced

February 4, 2012 By Leave a Comment

MyHealthNewsDaily, Cari Nierenberg

New Vaccine Recommendations

The nation’s largest pediatrician group today released its new schedule of recommended childhood vaccinations. It made three major changes to its previous recommendations, after a federal advisory panel of experts reviewed recent evidence from vaccine studies.

The biggest change is the new recommendation that boys should be vaccinated against human papillomavirus (HPV). Since 2006, the HPV vaccine has been recommended for girls, primarily to help prevent cervical cancer, and in 2009, the experts advised that boys “could” be given the shots, too.

The stronger wording in the new recommendations, that boys “should” be given the shots, came about because new data showed giving boys the vaccine can help lessen the odds of HPV-associated cancers in men and in women, said Dr. H. Cody Meissner, chief of pediatric infectious disease at the Floating Hospital for Children at Tufts Medical Center in Boston.

Read the entire article here.

 

Filed Under: Cervical Cancer, HPV Vax, Science & Medicine, The United States, Vaccine Science, Vaccines and the Media Tagged With: , , ,

A new voice in the HPV vaccine debate

February 4, 2012 By 1 Comment

CJAD 800 AM

Posted By: Dan Spector dspector@astral.com · 2/1/2012 10:01:00 PM

On a day when CJAD News was discussing the story of a family intending to sue a massive pharmaceutical company for $200 000 after their daughter died soon after receiving the anti-HPV (Human papillomavirus) vaccine Gardasil, researcher Dr. Lucija Tomljenovic joined Aaron for a fascinating discussion about the safety of the vaccine.

Dr.Tomljenovic hails from the Neural Dynamics Research Group at the University of British Columbia, and along with colleague Dr. Chris Shaw has published a controversial new study that asks: “Is it possible that HPV vaccines have been promoted to women based on inaccurate information?

Their essay was published online in late December in the medical journal Annals of Medicine.

To read about their findings, take a look at the following Medscape article. It sums up Tomljenovic and Shaw’s work nicely. If you’re interested in some of the controversy and backlash resulting from this study, scroll to the bottom.

January 31, 2012 — Is the policy for the human papillomavirus (HPV) vaccine at odds with evidence-based medicine?

Yes, according to an essay published online December 22, 2011, in the Annals of Medicine.

Canadian researchers Lucija Tomljenovic, PhD, and Christopher Shaw, PhD, from the Neural Dynamics Research Group, University of British Columbia, in Vancouver, point out that there is a major discrepancy in claims regarding the safety and efficacy of Gardasil (Merck & Co) and Cervarix (GlaxoSmithKline) — the 2 HPV vaccines that are currently on the market.

The vaccines have been heavily promoted in the United States by their respective manufacturers, the essayists report. In addition, the vaccines are backed by government agencies in the United States, including the Center for Disease Control and Prevention and the US Food and Drug Administration, and by medical authorities in a number of other countries.

HPV vaccination has been mired in controversy since the first vaccine was approved in the United States in 2006. There have been clashes among politicians, parents, professional and advocacy organizations, and public health officials, with heated exchanges over issues ranging from safety, the premise that vaccination will promote sexual activity in teens, cost, and concerns about aggressive lobbying by Merck to make the vaccine mandatory for girls.

Drs. Tomljenovic and Shaw note that skepticism about the vaccine has been increasing for a number of reasons, despite reassurances from the public-health sector. In their essay, they examine the current evidence to answer a key question: “Is it possible that HPV vaccines have been promoted to women based on inaccurate information?”

Does it Prevent Cancer?

One major issue is the claim made by medical authorities that HPV vaccines are an important tool in preventing cervical cancer. The efficacy of the vaccines in preventing cervical cancer has not been demonstrated because the study periods have been too short, say the essayists.

The longest follow-up from phase 2 trials for Gardasil is 5 years and for Cervarix is 8.4 years, but invasive cervical cancer can take 20 to 40 years to develop from the time of HPV infection.

“We don’t know the duration of the immune response of the vaccines,” Dr. Tomljenovic told Medscape Medical News, “so we don’t know if they are actually preventing cervical cancer or simply postponing it.”

Both vaccines very effectively prevent persistent infections with high-risk HPV types 16 and 18 and the associated cervical intraepithelial neoplasia (CIN) 2/3 lesions in HPV-naïve young women. However, note the essayists, even persistent HPV infections caused by high-risk strains generally do not lead to precursor lesions in the short term or to cervical cancer in the long term.

Read Full Article…

Filed Under: Canada, Cervical Cancer, HPV, Vaccine Politics/People Tagged With: , , , , , ,

Gardasil HPV Vaccine Now Being Promoted For HPV Of The Mouth

February 3, 2012 By Leave a Comment

Original post: AwareAndPrepare.com

Gardasil Marketing?

As we have reported before, it seems the MO for many vaccine manufacturers is to get a vaccine approved for one population, and then increase the use of the vaccine to as many more patient populations as possible, regardless of whether it is safe and effective or they need it or not.  Even with wide spread vaccine side effects, vaccine injury and even vaccine death related to the Gardasil HPV vaccine, attempts are being made for mandatory vaccinations of teenage boys, women over 40, and now, anyone with a mouth.

This will be used to promote the Gardasil HPV vaccine, even though it is only effective against a few strains of HPV while there are many strains of HPV.  People must do their due diligence when it comes to the thought of “to vaccinate or not”, benefit vs risk scenarios are often not optimally delivered by medical personal which often leads to vaccine side effects, vaccine injury and even vaccine death, whether we are dealing with mandatory vaccinations or not.

Read the entire article here.

Filed Under: HPV, HPV Vax, Oral Cancer, Vaccine Marketing Tagged With: , , , ,

Breaking news: cancer drugs make tumors more aggressive and deadly

January 20, 2012 By Leave a Comment

Natural News

by: S. L. Baker, features writer
January 19, 2012

When natural health advocates warn against mainstream medicine’s arsenal of weapons used to fight cancer, including chemotherapy and radiation, their concerns often revolve around how these therapies can weaken and damage a person’s body in numerous ways. But scientists are finding other reasons to question some of these therapies. It turns out that while chemotherapies may kill or shrink tumors in the short term, they may actually be causing malignancies to grow more deadly in the long term.

For example, NaturalNews previously reported (http://www.naturalnews.com/029042_cancer_cells_chemotherapy.html) that scientists at the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center and UAB Department of Chemistry are currently investigating the very real possibility that dead cancer cells left over after chemotherapy spark cancer to spread to other parts of the body (metastasis). And now comes news that a little-explored specific cell type, the pericyte, found in what is called the microenvironment of a cancerous tumor actually may halt cancer progression and metastasis. And by destroying these cells, some anti-cancer therapies may inadvertently be making cancer more aggressive as well as likely to spread and kill.

A study just published in the January 17 issue of the journal Cancer Cell concludes that anti-angiogenic therapies (which shrink cancer by cutting off tumors’ blood supply) may be killing the body’s natural defense against cancer by destroying pericyte cells that likely serve as important gatekeepers against cancer progression and metastasis. Pericytes cover blood vessels and support their growth.

For the new research, Raghu Kalluri, MD, PhD, Chief of the Division of Matrix Biology at Beth Israel Deaconess Medical Center (BIDMC) and Professor of Medicine at Harvard Medical School (HMS), investigated whether targeting pericytes could inhibit tumor growth in the same way that other antiangiogenic cancer drugs do.

Dr. Kalluri and his research team worked with mice genetically engineered to support drug-induced depletion of pericytes in growing tumors. Next, they removed pericytes in implanted mouse breast cancer tumors, decreasing pericyte numbers by 60 percent.

Compared with control animals, there was a 30 percent decrease in the size of cancerous tumors over 25 days. But there was a serious catch to these results. Contrary to conventional mainsteam medical wisdom, the scientists discovered the number of secondary lung tumors in the engineered mice had increased threefold compared to the control mice, indicating that the tumors had metastasized.

How cancer drugs can spread cancer cells

“If you just looked at tumor growth, the results were good,” Dr. Kalluri said in a press statement. “But when you looked at the whole picture, inhibiting tumor vessels was not controlling cancer progression. The cancer was, in fact, spreading. This suggested to us that without supportive pericytes, the vasculature inside the tumor was becoming weak and leaky — even more so than it already is inside most tumors– and this was reducing the flow of oxygen to the tumor.”

That change, he explains, makes cancer cells more mobile, so they can travel through those leaky vessels to new locations. It also makes cancer cells behave more like stem cells, so they are better able to survive.

Read Full Article…

Filed Under: Cancer, United States, Women's Health Tagged With: , , , , ,

The HPV vaccination is scientifically unnecessary

January 11, 2012 By 1 Comment

The staff comment below is in reaction to news that Guyana will begin immunizing girls 11 years old with Gardasil
Guyana to begin vaccinations to help stem cervical cancer

 

Starbroek News

Tuesday 10th January 2012
Georgetown, Guyana

By    Monday, January 9, 2012

Dear Editor,

I am writing to express my concern about the recently announced plans by Minister of Health Ramsaran to begin mass vaccination of schoolgirls in Guyana with the HPV vaccine on Wednesday, January 11, 2012. To a general public that is scientifically untrained, conditioned or browbeaten into not questioning those in authority, and easily manipulated, this may seem like a good initiative. We are told that HPV caused cervical cancer, and at that dreaded word, everyone is supposed to quietly and obediently line their daughters up for the injection. However, there are many serious issues with regard to this vaccine and proposed campaign that the Guyanese public should be aware of- from a public health as well as child rights perspective.

Speaking first to the public health issues- in my opinion as a trained public health professional and someone with years of experience in this field- this vaccine is unnecessary. The fact is that most HPV infections go away on their own, without treatment, and do not result in cancer. In the United States, where the prevalence of HPV infection is significantly higher than in Guyana, only about 3.4% of all HPV viruses were associated with cervical cancer [Source: http://jama.ama-assn.org/content/297/8/813.abstract?ijkey=85292b84748848d91264576bb538b4148404c962&keytype2=tf_ipsecsha. * Note- JAMA is the Journal of the American Medical Association- a highly credible publication, not some quack source.]

Also problematic is the fact that- with lack of proper public education about this vaccination effort (as happens so often in Guyana)- one of the unintended but inevitable consequences is likely to be that a significant number of sexually active girls and women will mistakenly believe that this vaccine also protects them from other sexually transmitted infections [it does not] and will then not use the appropriate protection or get the necessary testing to really safeguard themselves. So, in addition to being scientifically unnecessary, from a prevention standpoint- this mass vaccination could be even more harmful than helpful.

This vaccination campaign also makes no sense from a cost effective standpoint. Minister Ramsaran said that this was one of the most expensive vaccines in the vaccination programme. The fact is that the incidence of cervical cancer in Guyana (from the questionable data available) does not warrant such mass vaccination. While there have been reports of increasing numbers of cases over the last five years, that is explained by the fact that screening has also increased.

Any competent statistician will tell you that simply observing more of a thing when you’re looking out for it does not automatically mean that you have a problem.

In a country like Guyana when resources are scarce, data collection and statistically-credible, cost-benefit analysis need to be properly done and decisions more carefully made- with an eye towards providing the best possible services and care to the most people, not just looking good in the court of public opinion.

 

Filed Under: Cervical Cancer, Ghana, HPV Tagged With: , , ,

Skin Cancer Vaccine – A Silver Lining

November 19, 2011 By Leave a Comment

Med India

by Dr. Reeja Tharu on  November 12, 2011 at 2:53 PM Health Watch

Intro

Professor Ian Frazer, the Aussie cancer expert who discovered Gardasil says that he is on the edge of discovering a skin cancer vaccine.

This would potentially be a major break through that will save the lives of many. In Australia, two out of three people are affected by skin cancer.Virus and Cancer

“Genetics and variations in people’s immune systems may expose some people to greater risk of skin cancer after sun exposure,” observed Prof. Frazer.

Certain viruses such as the wart virus or HPV may be found embedded in the skin, which the professor believes, may then trigger the onset of cancer.

“The technology exists for me to test my theory. We will go hunting for the fingerprints of the virus or viruses,” he said.

This is proposed to be done by using the already available sequenced genetic information. The process would take up to six months.

“We will know if a virus causes skin cancer and what virus it is. Then we can make a vaccine straight away. If it turns out not to be a virus we would have learnt why some people get skin cancers and others don’t – it’s a win-win, “the professor said.

“In my lifetime we should be able to remove the threat of skin cancer from the next generation,” said the 57-year-old immunology professor. He indicated that a virus or a group of viruses could be causing the disease,” said Professor Ian Frazer.

Earlier, Professor Frazer identified the human papilloma virus (HPV) as the causative agent of cervical cancer and then went on to develop Gardasil, which is a vaccine against the HPV.

“This group of cancers, which are obviously associated with too much sun exposure, may be started off by a virus infection – which presents a great opportunity, because the idea of vaccinating to prevent a cancer is enormously appealing,” he remarked.

Filed Under: Australia, Cancer, Vaccine Science Tagged With: , , ,
« Older Posts

Safety Videos

sanevax-videos

Victim Videos

sanevax-videos2

Pharma Videos

cervarix 2

Vaccine Groups

center-for-personal-rights-logo

SaneVax Press Releases

Logo 1A